Parkwood LLC Rhythm Pharmaceuticals, Inc. Transaction History

Parkwood LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$35.41 - $44.37 $47,945 - $60,076	1,354 Added 9.01%	16,387 $673,000
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $189,145 - $253,547	4,835 Added 47.41%	15,033 $651,000
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $218,135 - $506,228	10,198 New	10,198 $469,000
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $27,024 - $54,818	1,601 Added 9.12%	19,147 $342,000
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $389,696 - $530,766	17,546 New	17,546 $511,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.